We are live on ! Find out more
KLRS

Kalaris Therapeutics
KLRS

71 hedge funds and large institutions have $854M invested in Kalaris Therapeutics in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more call options, than puts

Call options by funds: $19K | Put options by funds: $7K

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

51% more capital invested

Capital invested by funds: $566M → $854M (+$288M)

16% more funds holding

Funds holding: 61 → 71 (+10)

0.17% more ownership

Funds ownership: 1.4% → 1.56% (+0.17%)

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
23
Reduced
14
Closed
12
Calls
$19K
Puts
$7K
Net Calls
+$12K
Net Calls Change
+$16K

Top Buyers

Rank Fund Capital Flow
1
AIG
American International Group
New York
+$30.1M
2
BlackRock
BlackRock
New York
+$21.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.4M
4
State Street
State Street
Massachusetts
+$16.9M
5
TG
TCW Group
California
+$7.23M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$8.97M
2
MWNA
Marshall Wace North America
New York
-$8.57M
3
WP
Woodline Partners
California
-$5.06M
4
Goldman Sachs
Goldman Sachs
New York
-$1.07M
5
SCM
Suvretta Capital Management
New York
-$1.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$270M +$18.4M +23,961 +8%
RG
2
Redmile Group
California
$89.4M -$261K -339 -0.3%
AG
3
Artal Group
Luxembourg
$89.3M – – –
BlackRock
4
BlackRock
New York
$69.8M +$21.5M +27,955 +55%
Vanguard Group
5
Vanguard Group
Pennsylvania
$54.2M +$1.79M +2,327 +4%
Alkeon Capital Management
6
Alkeon Capital Management
New York
$42.2M – – –
WP
7
Woodline Partners
California
$40M -$5.06M -6,571 -13%
AllianceBernstein
8
AllianceBernstein
Tennessee
$39.3M +$2.1M +2,734 +7%
State Street
9
State Street
Massachusetts
$29M +$16.9M +21,941 +202%
Massachusetts Financial Services
10
Massachusetts Financial Services
Massachusetts
$24.1M +$391K +508 +2%
EC
11
EcoR1 Capital
California
$17.2M – – –
MWNA
12
Marshall Wace North America
New York
$12.5M -$8.57M -11,140 -44%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$11.9M +$366K +476 +4%
TG
14
TCW Group
California
$8.31M +$7.23M +9,397 New
Northern Trust
15
Northern Trust
Illinois
$8.19M -$19.2K -25 -0.3%
ACH
16
ArrowMark Colorado Holdings
Colorado
$4.8M – – –
AA
17
ALPS Advisors
Colorado
$4.52M +$3.94M +5,117 New
Charles Schwab
18
Charles Schwab
California
$4.36M +$132K +171 +4%
N
19
Nuveen
North Carolina
$3.05M +$132K +171 +5%
First Trust Advisors
20
First Trust Advisors
Illinois
$2.61M +$2.27M +2,949 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$2.6M +$498K +647 +28%
Carson Wealth (CWM LLC)
22
Carson Wealth (CWM LLC)
Nebraska
$2.22M – – –
Norges Bank
23
Norges Bank
Norway
$1.92M – – –
Morgan Stanley
24
Morgan Stanley
New York
$1.7M +$1.33M +1,735 +913%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$1.46M -$23.8K -31 -2%
1
2 3 4

KLRS Hedge Fund Activity: Q4 2020 in Review

71 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Kalaris Therapeutics (KLRS) for Q4 2020, worth a combined $854M — up 51% from $566M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new KLRS positions and 12 closed out — a net gain of 10 holders — while 23 added to existing stakes and 14 trimmed.

The largest buyer was American International Group, adding an estimated $30.1M. The largest seller was Sectoral Asset Management, cutting an estimated $8.97M.

  • 71 institutional investors held Kalaris Therapeutics (KLRS) as of Q4 2020, up from 61 in Q3 2020.
  • Funds reported $854M of Kalaris Therapeutics stock for Q4 2020, up 51% quarter-over-quarter.
  • 22 funds opened new Kalaris Therapeutics positions in Q4 2020 and 12 closed out, a net change of +10 holders.
  • The largest Kalaris Therapeutics buyer in Q4 2020 was American International Group, an estimated $30.1M added.
  • The largest Kalaris Therapeutics seller in Q4 2020 was Sectoral Asset Management, an estimated $8.97M sold.

Based on aggregated 13F filings for Q4 2020.